Belgian radiopharmaceutical firm Ion Beam Applications (IBA) has signed an exclusive distribution deal with Lantheus Medical Imaging.
IBA will distribute the North Billerica, MA-based firm's Cardiolite and Neurolite radiopharmaceuticals in several European countries, including France, Germany, the U.K., and Spain. The agreement takes effect September 1, according to IBA of Louvain-la-Neuve, Belgium.
Related Reading
Lantheus reports data from cardiac PET trial, June 17, 2008
IBA, Wilex ink licensing pact, June 6, 2008
IBA finalizes acquisition of CIS bio, May 30, 2008
Lantheus updates Definity label, May 13, 2008
Lantheus launches new Definity trial, May 7, 2008
IBA opens U.K. production center, March 14, 2008
Copyright © 2008 AuntMinnie.com
